Fear Not the Fungus Treatment - Frankly Speaking EP 122

Pri-Med Podcasts

English - May 27, 2019 04:30 - 10 minutes - 19.5 MB - ★★★★★ - 71 ratings
Life Sciences Science Health & Fitness education faq medical primed Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Preventing Perinatal Depression: Recommendations to Improve Outcomes for Moms and Their Babies - Frankly Speaking EP 121

Next Episode: Contraceptive Education: Educate Your Patients While They Wait - Frankly Speaking EP 123

Credits: 0.25 AMA PRA Category 1 Credits™

Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-113-deprescribing

Overview: Since their arrival, oral anti-fungal agents have been thought to induce liver disease. Often, these medications are avoided or used with caution and frequent laboratory testing. Join us in a discussion of a recent study that builds on previous work showing the risk with using these agents is extremely small.

Guest: Susan Feeney, DNP, FNP

Landing Page: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-122